BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2164200)

  • 21. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils.
    Svetlov S; Nigam S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):162-6. PubMed ID: 8380690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ; Shukla SD
    J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific binding sites of platelet activating factor on the intact bovine cerebral microvascular endothelial cells and antagonism of drugs.
    Sun DX; Rui YC; Zeng GQ; Zhu J; Shen YA
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):326-9. PubMed ID: 1333718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degree of platelet activating factor-induced neutrophil migration is dependent upon the molecular species.
    Carolan EJ; Casale TB
    J Immunol; 1990 Oct; 145(8):2561-5. PubMed ID: 2170519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of platelet-activating factor receptors on canine T lymphocytes.
    Mangino MJ; Murphy MK; Weiss A; Anderson CB
    J Immunol; 1993 Nov; 151(10):5310-8. PubMed ID: 8228226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation by IL-5 of expression of functional platelet-activating factor receptors on human eosinophils.
    Kishimoto S; Shimadzu W; Izumi T; Shimizu T; Fukuda T; Makino S; Sugiura T; Waku K
    J Immunol; 1996 Nov; 157(9):4126-32. PubMed ID: 8892648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism and regulation of neutrophil priming by platelet-activating factor.
    Gay JC
    J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.
    Hwang SB
    J Lipid Mediat; 1990; 2(3-4):123-58. PubMed ID: 1966805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAF binding to a single receptor in corneal epithelium plasma membrane.
    Hurst J; Ma X; Bazan HE
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):790-5. PubMed ID: 10067986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
    Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
    Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
    Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
    J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
    Chen J; Ziboh V; Giri SN
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Degranulation of human eosinophilic granulocytes by the platelet activating factor].
    Kroegel C; Venge P; Matthys H; Barnes PJ
    Pneumologie; 1990 Feb; 44 Suppl 1():234-5. PubMed ID: 2367375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulatory role of protein kinase C on the signal transduction pathway utilized by platelet-activating factor in eosinophil activation.
    Kroegel C; Giembycz MA; Matthys H; Westwick J; Barnes PJ
    Am J Respir Cell Mol Biol; 1994 Nov; 11(5):593-9. PubMed ID: 7946388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium.
    Schwinger RH; Böhm M; La Rosée K; Erdmann E
    Am Heart J; 1992 Aug; 124(2):320-30. PubMed ID: 1322030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activating factor stimulates a receptor-coupled membrane GTPase in guinea pig eosinophils.
    Dent G; Barnes PJ
    Life Sci; 1993; 52(20):1633-40. PubMed ID: 8387140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function.
    Dent G; Ukena D; Chanez P; Sybrecht G; Barnes P
    FEBS Lett; 1989 Feb; 244(2):365-8. PubMed ID: 2537761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
    Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
    Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.